A University of Dundee expert has been appointed to lead a new centre that will drive research to better understand the ...

L'Italia è tutta un set. Sono tantissime le fiction che si girano tra giugno e settembre: ecco dove vedere i vostri beniamini al lavoro.

“The LITE initiative seeks to provide opportunities for better understanding Parkinson's and treating it,” said Dario Alessi, PhD, Director of the MRC Protein Phosphorylation Unit at the ...

Montara Therapeutics awarded $3.3 million non-dilutive MJFF grant to develop BrainOnly™ Parkinson's therapy targeting LRRK2, a genetically validated target with major drug development challenges.; New ...

Focus on the discovery of next-generation LRRK2 inhibitors to unlock novel biological mechanisms of action and advance new treatment options YONGIN, South Korea, April 15, 2025 – 1ST ...

The LITE initiative, led by Dario Alessi, PhD, a renowned kinase researcher at the University of Dundee, brings together more than 20 leading academic institutions and 20 biotech and pharmaceutical ...

UNIVERSITY of Dundee scientist Professor Dario Alessi is to lead a new research programme in hopes of helping with medical advancements targeting inherited Parkinson’s disease. The program ...

LITE will be led by Professor Dario Alessi, who is a global leader in the study of kinases which is a class of cellular proteins that includes LRRK2.

LITE will be led by Professor Dario Alessi, a global leader in the study of kinases, a class of cellular proteins that includes LRRK2. Professor Alessi runs a lab focused on kinase research at the ...

Dario Alessi, director of the MRC PPU said: “We are incredibly grateful for the long-term support that our unit has received from the MRC over the last 34 years. This has enabled our researchers to ...

Remaining members were Dario Alessi, Director of the MRC Protein Phosphorylation and Ubiquitylation Unit at Dundee University (United Kingdom); ...